Journal of Gastroenterology

, Volume 53, Issue 5, pp 652–659 | Cite as

Application of transcutaneous ultrasonography for the diagnosis of muscle mass loss in patients with liver cirrhosis

  • Kazufumi Kobayashi
  • Hitoshi MaruyamaEmail author
  • Soichiro Kiyono
  • Sadahisa Ogasawara
  • Eiichiro Suzuki
  • Yoshihiko Ooka
  • Tetsuhiro Chiba
  • Naoya Kato
  • Tadashi Yamaguchi
Original Article—Liver, Pancreas, and Biliary Tract



To propose an ultrasound-based parameter for the diagnosis of muscle mass loss (MML) in cirrhosis.


This is an IRB-approved cross-sectional study (October 2013 to January 2017) with written informed consent including 357 subjects—234 cirrhosis and 123 controls. MML was diagnosed using the skeletal muscle index at the L3 level (L3-SMI) on computed tomography (CT). Transcutaneous ultrasound was used to demonstrate a cross section of the right iliopsoas muscle, and the iliopsoas muscle index (IP index) was defined by the iliopsoas muscle area/height2 (mm2/m2). Receiver operating characteristic (ROC) curve analysis was performed to assess the diagnostic ability of IP index for MML.


The iliopsoas muscle was detected in all subjects. The IP index was lower in cirrhosis than in controls: males (211.2 ± 73.8 vs. 295.5 ± 139.4, P < 0.0001) and females (200.2 ± 72.5 vs. 284.4 ± 112.4, P < 0.0001). L3-SMI and IP index showed correlations in males (r = 0.699, P < 0.0001) and in females (r = 0.707, P < 0.0001). Independent factors for MML by multivariate analysis were body mass index and IP index in both males and females. Sensitivity, specificity, and area under the ROC curve by IP index to detect MML were 79.5%, 73.1%, and 0.835, respectively, with the best cut-off value of 189.2 for males, and 84.6%, 78.8%, and 0.874, respectively, with the best cut-off value of 180.6 for females.


Using transcutaneous ultrasound, the IP index may be a valuable diagnostic parameter for MML in cirrhosis.


Muscle mass loss Ultrasound Cirrhosis Non-invasive diagnosis 


Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest and have not received any financial support for this work.


  1. 1.
    Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis. 2008;28:110–22.CrossRefPubMedGoogle Scholar
  3. 3.
    Cardenas A, Gines P. Management of patients with cirrhosis awaiting liver transplantation. Gut. 2011;60:412–21.CrossRefPubMedGoogle Scholar
  4. 4.
    Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–73.CrossRefPubMedGoogle Scholar
  5. 5.
    Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis. 2012;16:95–131.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.CrossRefPubMedGoogle Scholar
  7. 7.
    Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transplant. 2012;18:1209–16.CrossRefGoogle Scholar
  8. 8.
    Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271–8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:861–70.CrossRefPubMedGoogle Scholar
  10. 10.
    Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant. 2013;13:1549–56.CrossRefPubMedGoogle Scholar
  11. 11.
    Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115–22.CrossRefPubMedGoogle Scholar
  12. 12.
    Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Sergi G, Trevisan C, Veronese N, et al. Imaging of sarcopenia. Eur J Radiol. 2016;85:1519–24.CrossRefPubMedGoogle Scholar
  14. 14.
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 1997;113:1609–16.CrossRefPubMedGoogle Scholar
  16. 16.
    Colli A, Fraquelli M, Andreoletti M, et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection—analysis of 300 cases. Radiology. 2003;227:89–94.CrossRefPubMedGoogle Scholar
  17. 17.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Nishikawa H, Shiraki M, Hiramatsu A, et al. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016;46:951–63.CrossRefPubMedGoogle Scholar
  19. 19.
    Kondo T, Maruyama H, Sekimoto T, et al. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis. Scand J Gastroenterol. 2016;51:236–44.CrossRefPubMedGoogle Scholar
  20. 20.
    Masuda T, Shirabe K, Ikegami T, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transplant. 2014;20:401–7.CrossRefGoogle Scholar
  21. 21.
    Hamaguchi Y, Kaido T, Okumura S, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transplant. 2014;20:1413–9.CrossRefGoogle Scholar
  22. 22.
    Hanai T, Shiraki M, Nishimura K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31:193–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMedGoogle Scholar
  24. 24.
    Cardinot TM, Aragao AH, Babinski MA, et al. Rare variation in course and affluence of internal iliac vein due to its anatomical and surgical significance. Surg Radiol Anat. 2006;28:422–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Kose MF, Turan T, Karasu Y, et al. Anomalies of major retroperitoneal vascular structure. Int J Gynecol Cancer. 2011;21:1312–9.PubMedGoogle Scholar
  26. 26.
    Arts IM, Pillen S, Overeem S, et al. Rise and fall of skeletal muscle size over the entire life span. J Am Geriatr Soc. 2007;55:1150–2.CrossRefPubMedGoogle Scholar
  27. 27.
    Arts IM, Pillen S, Schelhaas HJ, et al. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve. 2010;41:32–41.CrossRefPubMedGoogle Scholar
  28. 28.
    Fukumoto Y, Ikezoe T, Yamada Y, et al. Age-related ultrasound changes in muscle quantity and quality in women. Ultrasound Med Biol. 2015;41:3013–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Tandon P, Low G, Mourtzakis M, et al. A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:1473–80.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2017

Authors and Affiliations

  • Kazufumi Kobayashi
    • 1
  • Hitoshi Maruyama
    • 1
    Email author
  • Soichiro Kiyono
    • 1
  • Sadahisa Ogasawara
    • 1
  • Eiichiro Suzuki
    • 1
  • Yoshihiko Ooka
    • 1
  • Tetsuhiro Chiba
    • 1
  • Naoya Kato
    • 1
  • Tadashi Yamaguchi
    • 2
  1. 1.Department of GastroenterologyChiba University Graduate School of MedicineChibaJapan
  2. 2.Center for Frontier Medical EngineeringChiba UniversityChibaJapan

Personalised recommendations